NDC 80425-0121-07 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0121
- Requested NDC
- 80425-0121-07
- Package NDCs from labels
- 80425-0121-4, 80425-0121-1, 80425-0121-2, 80425-0121-3, 80425-0121-5, 80425-0121-6, 80425-0121-7, 80425-0121-07
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0121-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 10 | |
| 80425-0121-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 10 | |
| 80425-0121-3 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 10 | |
| 80425-0121-4 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 10 | |
| 80425-0121-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 10 | |
| 80425-0121-6 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 10 | |
| 80425-0121-7 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0121 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 7 package rows | 20240119_b6ffe633-dd91-6d49-e053-2a95a90a5ac6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0121-1 | EA - Each | 80425-0121 | b098bd7f-bb96-4b61-a21d-97eace448f0c | 1 | 2023-03-13 |
| 80425-0121-2 | EA - Each | 80425-0121 | 426ea2b8-26c1-43e8-a5b1-1672b92f5233 | 1 | 2023-03-13 |
| 80425-0121-3 | EA - Each | 80425-0121 | 7fc1df44-2cd9-4b79-ae4c-de04aadf60a9 | 1 | 2023-03-13 |
| 80425-0121-4 | EA - Each | 80425-0121 | 565cd629-53b3-43a8-a2d5-ea15be49d06e | 1 | 2023-03-13 |
| 80425-0121-5 | EA - Each | 80425-0121 | d48bfbc1-a630-44dc-a60e-afcb09a91657 | 1 | 2023-03-13 |
| 80425-0121-6 | EA - Each | 80425-0121 | 2aca4026-c892-49c5-a382-fcec45451772 | 1 | 2023-10-16 |
| 80425-0121-7 | EA - Each | 80425-0121 | dd7a169c-9ad3-407c-8d7b-6183f03ecc0e | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Northwind Health Company, LLC | 4ecf9314-76e2-c270-e063-6294a90ad8db | 2026-09-03 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | c0ca008e-0e28-412e-a58f-70f63817713b | 2026-09-01 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Lupin Pharmaceuticals, Inc. | 1d3e6d33-5dc2-498e-8efa-e3c4fca15dff | 2026-08-24 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | HAWAII REPACK, INC. | d54abc0a-3c8f-4f02-bd55-406f0c5b925a | 2026-08-18 | Warnings, Adverse reactions | ANDA090836 309114 637173 645617 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | 864d2046-b2c8-415c-814b-512bc4901c76 | 2026-08-12 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | c600a2c0-42ab-4be8-b9b1-59ba39494b3f | 2026-08-07 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | af3e9919-3812-4917-bb6e-266a692ee4ab | 2026-08-07 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | a24a3c7c-c0f8-4107-ab30-751bea743d2d | 2026-08-07 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 3dc725a0-6e4b-45c6-9569-34ef65455845 | 2026-08-07 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | e4e1ebcf-b43b-4dbe-9295-eeef67ba6272 | 2026-08-07 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b73593ce-0b1f-4371-bae1-140742de3b42 | 2026-08-06 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | d3527c0a-94e4-46a2-be77-d936abcd19ec | 2026-08-03 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 2506895d-f3e0-4be9-95cb-7a6fd44de46d | 2026-08-03 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | AvKARE | 03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d | 2026-07-29 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals Inc. | 88426cb3-1c0c-439b-9f1a-aa169040c29f | 2026-07-23 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | a6b5edf2-1ef8-46b7-977a-8c303900f3f0 | 2026-07-22 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | 655f38e8-1c4d-4cbc-9f52-bb881f065b2d | 2026-07-21 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 0384c418-b4d4-4c06-9ed9-13e864b1980b | 2026-07-16 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | d6954168-9c7f-4a6c-9262-2e6bed5c9f24 | 2026-07-14 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 7508351d-69fe-457c-b450-9a2343be2587 | 2026-07-14 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.